StockData
CTT Pharmaceutical Holdings, Inc. logo

CTT Pharmaceutical Holdings, Inc. (CTTH) shareholders

CTTHOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2015, quý kết thúc ngày Sep 30, 2015Last filing: 10-Q on Nov 18, 2026
$0.06−0.00 (-0.17%)

Close on Oct 16, 2026Market cap $1.26MP/E –Yield –

Ownership

Who owns CTT Pharmaceutical's shares

Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
21 buys · 0 sales
Net bought $16.89K

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Ctt Pharmaceutical Holdings, Inc.CEO, Director9,454,03615.83%Nov 16, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Ctt Pharmaceutical Holdings, Inc.
CEO, Director
Nov 12, 2026Buy+1,500$0.05$819,454,036
Ctt Pharmaceutical Holdings, Inc.
CEO, Director
Nov 4, 2026Buy+9,000$0.05$4509,452,536
Ctt Pharmaceutical Holdings, Inc.
CEO, Director
Oct 26, 2026Buy+5,880$0.06$3359,442,536
Ctt Pharmaceutical Holdings, Inc.
CEO, Director
Oct 15, 2026Buy+2,000$0.06$1149,436,656
Ctt Pharmaceutical Holdings, Inc.
CEO, Director
Oct 6, 2026Buy+3,700$0.06$2049,433,656
Ctt Pharmaceutical Holdings, Inc.
CEO, Director
Sep 28, 2026Buy+3,400$0.06$2049,429,956
Ctt Pharmaceutical Holdings, Inc.
CEO, Director
Sep 22, 2026Buy+10,100$0.05$5059,424,556
Ctt Pharmaceutical Holdings, Inc.
CEO, Director
Sep 22, 2026Buy+10,100$0.05$5051,056,800
Ctt Pharmaceutical Holdings, Inc.
CEO, Director
Sep 16, 2026Buy+10,900$0.05$5459,414,456
Ctt Pharmaceutical Holdings, Inc.
CEO
Sep 10, 2026Buy+3,500$0.05$1759,400,556
Ctt Pharmaceutical Holdings, Inc.
CEO
Sep 4, 2026Buy+9,800$0.05$4909,397,056
Ctt Pharmaceutical Holdings, Inc.
CEO
Sep 2, 2026Buy+3,000$0.05$1509,387,256
Ctt Pharmaceutical Holdings, Inc.
CEO
Aug 31, 2026Buy+3,500$0.05$1759,384,256
Ctt Pharmaceutical Holdings, Inc.
CEO
Aug 24, 2026Buy+2,100$0.06$1269,360,756
Ctt Pharmaceutical Holdings, Inc.
CEO
Aug 20, 2026Buy+11,500$0.05$5759,378,656
Ctt Pharmaceutical Holdings, Inc.
CEO
Aug 19, 2026Buy+10,000$0.06$6009,365,456
Ctt Pharmaceutical Holdings, Inc.
CEO
Aug 14, 2026Buy+1,800$0.06$1089,355,456
Ctt Pharmaceutical Holdings, Inc.
CEO
Aug 7, 2026Buy+7,700$0.07$5399,353,656
Ctt Pharmaceutical Holdings, Inc.
CEO
Dec 17, 2025Buy+8,300$0.06$4987,845,956
Ctt Pharmaceutical Holdings, Inc.
Director
Nov 20, 2025Buy+200,000$0.04$8.00K3,734,003
Ctt Pharmaceutical Holdings, Inc.
CEO
Nov 20, 2025Buy+62,900$0.04$2.52K7,837,656
Ctt Pharmaceutical Holdings, Inc.
CEO
Oct 31, 2025Buy+7,000$0.06$4207,774,756
Ctt Pharmaceutical Holdings, Inc.
CEO
Sep 23, 2025Buy+6,815$0.06$4097,767,756
Ctt Pharmaceutical Holdings, Inc.
CEO
Aug 2, 2025Buy+44,085$0.05$2.20K7,760,941
Ctt Pharmaceutical Holdings, Inc.
CEO
Aug 1, 2025Award+750,000$0.04$30.00K7,716,856
Ctt Pharmaceutical Holdings, Inc.
CEO
Aug 1, 2025Buy+15,800$0.04$6326,966,856
Ctt Pharmaceutical Holdings, Inc.
CEO
Jul 8, 2025Buy+8,000$0.03$2406,951,056
Ctt Pharmaceutical Holdings, Inc.
CEO
Jun 26, 2025Buy+39,600$0.03$1.19K6,943,056
Ctt Pharmaceutical Holdings, Inc.
CEO
Jun 23, 2025Buy+16,100$0.03$4836,903,456
Ctt Pharmaceutical Holdings, Inc.
CEO
Jun 9, 2025Buy+82,158$0.05$4.11K6,832,558
Ctt Pharmaceutical Holdings, Inc.
CEO
Apr 11, 2025Award+150,000$0.06$9.00K6,750,400
Ctt Pharmaceutical Holdings, Inc.
CEO
Apr 9, 2025Buy+9,984$0.07$6996,600,400
Ctt Pharmaceutical Holdings, Inc.
CEO
Mar 31, 2025Buy+15,510$0.05$7766,590,416
Ctt Pharmaceutical Holdings, Inc.
CEO
Mar 11, 2025Buy+5,400$0.06$3246,574,906
Ctt Pharmaceutical Holdings, Inc.
CEO
Mar 7, 2025Buy+11,950$0.09$1.08K6,569,506
Ctt Pharmaceutical Holdings, Inc.
CEO
Feb 5, 2025Buy+5,200$0.12$6246,557,556
Ctt Pharmaceutical Holdings, Inc.
CEO
Nov 25, 2024Buy+23,346$0.06$1.40K5,818,846
Ctt Pharmaceutical Holdings, Inc.
CEO
Sep 11, 2024Award+750,000$0.04$30.00K5,795,500
Ctt Pharmaceutical Holdings, Inc.
CEO
Sep 11, 2024Buy+750$0.06$455,045,500
Ctt Pharmaceutical Holdings, Inc.
CEO
Sep 11, 2024Buy+1,100$0.06$665,044,750
Ctt Pharmaceutical Holdings, Inc.
CEO
Aug 27, 2024Buy+550$0.06$335,042,650
Ctt Pharmaceutical Holdings, Inc.
CEO
Aug 19, 2024Buy+2,900$0.05$1455,042,100
Ctt Pharmaceutical Holdings, Inc.
CEO
Aug 12, 2024Buy+1,300$0.04$525,039,200
Ctt Pharmaceutical Holdings, Inc.
CEO
Aug 6, 2024Buy+2,200$0.04$885,037,900
Ctt Pharmaceutical Holdings, Inc.
CEO
Aug 5, 2024Buy+1,000$0.04$405,035,700
Ctt Pharmaceutical Holdings, Inc.
CEO
Aug 3, 2024Buy+1,000$0.06$605,043,650
Ctt Pharmaceutical Holdings, Inc.
CEO
Aug 1, 2024Buy+1,600$0.04$645,034,700
Ctt Pharmaceutical Holdings, Inc.
CEO
Jul 26, 2024Buy+3,100$0.04$1245,033,100
Ctt Pharmaceutical Holdings, Inc.
CEO
Jul 24, 2024Buy+1,700$0.04$685,030,000
Ctt Pharmaceutical Holdings, Inc.
CEO
Jul 18, 2024Buy+2,000$0.05$1005,028,300
Ctt Pharmaceutical Holdings, Inc.
CEO
Jul 16, 2024Buy+1,800$0.06$1085,026,300
Ctt Pharmaceutical Holdings, Inc.
CEO
Jul 11, 2024Buy+1,070$0.06$645,024,500
Ctt Pharmaceutical Holdings, Inc.
CEO
Jul 11, 2024Buy+2,730$0.06$1645,023,430
Ctt Pharmaceutical Holdings, Inc.
CEO
Jul 5, 2024Buy+1,454$0.06$875,020,700
Ctt Pharmaceutical Holdings, Inc.
CEO
Jun 25, 2024Buy+1,300$0.06$785,019,246
Ctt Pharmaceutical Holdings, Inc.
CEO
Jun 20, 2024Buy+1,000$0.07$705,017,946
Ctt Pharmaceutical Holdings, Inc.
CEO
Jun 13, 2024Buy+54,798$0.03$1.64K6,887,356
Ctt Pharmaceutical Holdings, Inc.
CEO
Jun 12, 2024Award+86,956$0.03$2.61K5,016,946
Ctt Pharmaceutical Holdings, Inc.
CEO
Jun 11, 2024Buy+1,990$0.05$1004,929,990
Ctt Pharmaceutical Holdings, Inc.
CEO
Jun 3, 2024Buy+7,376$0.02$1484,158,000

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
–
0M shares short
Days to cover
1.0
At 0M shares a day
Change since last report
+5.5%
From 0M shares
Short volume, 0 days
–
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of CTT Pharmaceutical's stock actually held short. Settlement fails (shares not delivered on time) peaked at 5,092 shares on Oct 6, 2026 over the last 90 days.

See a number that looks wrong?